ASPP2 deficiency promotes the progression of metabolic dysfunction-associated steatohepatitis via ACSL4 upregulation

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: ASPP2 deficiency promotes the progression of metabolic dysfunction-associated steatohepatitis via ACSL4 upregulation ; volume:14 ; number:1 ; day:25 ; month:11 ; year:2024 ; pages:1-13 ; date:12.2024
Scientific reports ; 14, Heft 1 (25.11.2024), 1-13, 12.2024

Creator: Wang, Jinming
Li, Quanwei
Huo, Yunfei
Liu, Xiaoni
Shi, Ying
Xie, Bangxiang

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41598-024-80415-0

URN: urn:nbn:de:101:1-2502102123034.705662494581

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:38 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Wang, Jinming
Li, Quanwei
Huo, Yunfei
Liu, Xiaoni
Shi, Ying
Xie, Bangxiang
SpringerLink (Online service)

Other Objects (12)

Intestinal Atp8b1 dysfunction causes hepatic choline deficiency and steatohepatitis

Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis

Inhibition of hepatic oxalate overproduction ameliorates metabolic dysfunction-associated steatohepatitis

Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA+ B cells

Upregulation of CENPM promotes hepatocarcinogenesis through mutiple mechanisms

WWOX promotes osteosarcoma development via upregulation of Myc

Deficiency of WTAP in hepatocytes induces lipoatrophy and non-alcoholic steatohepatitis (NASH)

NDRG1 upregulation by ubiquitin proteasome system dysfunction aggravates neurodegeneration

TRPV1-mediated UCP2 upregulation ameliorates hyperglycemia-induced endothelial dysfunction

Sphingosine d18:1 promotes nonalcoholic steatohepatitis by inhibiting macrophage HIF-2α

Nichtalkoholische Steatohepatitis (NASH) und alkoholische Steatohepatitis (ASH)

TET2 deficiency promotes MDS-associated leukemogenesis

Intestinal Atp8b1 dysfunction causes hepatic choline deficiency and steatohepatitis

Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis

Inhibition of hepatic oxalate overproduction ameliorates metabolic dysfunction-associated steatohepatitis

Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA+ B cells

Upregulation of CENPM promotes hepatocarcinogenesis through mutiple mechanisms

WWOX promotes osteosarcoma development via upregulation of Myc

Deficiency of WTAP in hepatocytes induces lipoatrophy and non-alcoholic steatohepatitis (NASH)

NDRG1 upregulation by ubiquitin proteasome system dysfunction aggravates neurodegeneration

TRPV1-mediated UCP2 upregulation ameliorates hyperglycemia-induced endothelial dysfunction

Sphingosine d18:1 promotes nonalcoholic steatohepatitis by inhibiting macrophage HIF-2α

Nichtalkoholische Steatohepatitis (NASH) und alkoholische Steatohepatitis (ASH)

TET2 deficiency promotes MDS-associated leukemogenesis

Intestinal Atp8b1 dysfunction causes hepatic choline deficiency and steatohepatitis

Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis

Inhibition of hepatic oxalate overproduction ameliorates metabolic dysfunction-associated steatohepatitis

Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA+ B cells

Upregulation of CENPM promotes hepatocarcinogenesis through mutiple mechanisms

WWOX promotes osteosarcoma development via upregulation of Myc

Deficiency of WTAP in hepatocytes induces lipoatrophy and non-alcoholic steatohepatitis (NASH)

NDRG1 upregulation by ubiquitin proteasome system dysfunction aggravates neurodegeneration

TRPV1-mediated UCP2 upregulation ameliorates hyperglycemia-induced endothelial dysfunction

Sphingosine d18:1 promotes nonalcoholic steatohepatitis by inhibiting macrophage HIF-2α

Nichtalkoholische Steatohepatitis (NASH) und alkoholische Steatohepatitis (ASH)

TET2 deficiency promotes MDS-associated leukemogenesis

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

ASPP2 deficiency promotes the progression of metabolic dysfunction-associated steatohepatitis via ACSL4 upregulation

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Intestinal Atp8b1 dysfunction causes hepatic choline deficiency and steatohepatitis

Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis

Inhibition of hepatic oxalate overproduction ameliorates metabolic dysfunction-associated steatohepatitis

Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA+ B cells

Upregulation of CENPM promotes hepatocarcinogenesis through mutiple mechanisms

WWOX promotes osteosarcoma development via upregulation of Myc

Deficiency of WTAP in hepatocytes induces lipoatrophy and non-alcoholic steatohepatitis (NASH)

NDRG1 upregulation by ubiquitin proteasome system dysfunction aggravates neurodegeneration

TRPV1-mediated UCP2 upregulation ameliorates hyperglycemia-induced endothelial dysfunction

Sphingosine d18:1 promotes nonalcoholic steatohepatitis by inhibiting macrophage HIF-2α

Nichtalkoholische Steatohepatitis (NASH) und alkoholische Steatohepatitis (ASH)

TET2 deficiency promotes MDS-associated leukemogenesis

Intestinal Atp8b1 dysfunction causes hepatic choline deficiency and steatohepatitis

Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis

Inhibition of hepatic oxalate overproduction ameliorates metabolic dysfunction-associated steatohepatitis

Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA+ B cells

Upregulation of CENPM promotes hepatocarcinogenesis through mutiple mechanisms

WWOX promotes osteosarcoma development via upregulation of Myc

Deficiency of WTAP in hepatocytes induces lipoatrophy and non-alcoholic steatohepatitis (NASH)

NDRG1 upregulation by ubiquitin proteasome system dysfunction aggravates neurodegeneration

TRPV1-mediated UCP2 upregulation ameliorates hyperglycemia-induced endothelial dysfunction

Sphingosine d18:1 promotes nonalcoholic steatohepatitis by inhibiting macrophage HIF-2α

Nichtalkoholische Steatohepatitis (NASH) und alkoholische Steatohepatitis (ASH)

TET2 deficiency promotes MDS-associated leukemogenesis

Intestinal Atp8b1 dysfunction causes hepatic choline deficiency and steatohepatitis

Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis

Inhibition of hepatic oxalate overproduction ameliorates metabolic dysfunction-associated steatohepatitis

Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA+ B cells

Upregulation of CENPM promotes hepatocarcinogenesis through mutiple mechanisms

WWOX promotes osteosarcoma development via upregulation of Myc

Deficiency of WTAP in hepatocytes induces lipoatrophy and non-alcoholic steatohepatitis (NASH)

NDRG1 upregulation by ubiquitin proteasome system dysfunction aggravates neurodegeneration

TRPV1-mediated UCP2 upregulation ameliorates hyperglycemia-induced endothelial dysfunction

Sphingosine d18:1 promotes nonalcoholic steatohepatitis by inhibiting macrophage HIF-2α

Nichtalkoholische Steatohepatitis (NASH) und alkoholische Steatohepatitis (ASH)

TET2 deficiency promotes MDS-associated leukemogenesis

Related objects

Reset password